Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 77,016 | 211,928 | 318 | 328 | 115 |
| Gross Profit | 77,016 | 211,928 | 318 | 328 | 115 |
| Operating Expenses | 66,033 | 72,765 | 55,301 | 48,751 | 45,343 |
| Operating Income | 10,983 | 139,163 | -54,983 | -48,423 | -45,228 |
| Other Income | 19,563 | -466 | 1,369 | 100 | -2,128 |
| Pre-tax Income | 30,546 | 138,697 | -53,614 | -48,323 | -47,356 |
| Income Tax | 4 | 274 | 85 | 85 | 234 |
| Net Income Continuous | 30,542 | 138,423 | -53,699 | -48,408 | -47,590 |
| Net Income | $30,542 | $138,423 | $-53,699 | $-48,408 | $-47,590 |
| EPS Basic Total Ops | 0.65 | 2.52 | -1.01 | -0.93 | -0.93 |
| EPS Basic Continuous Ops | 0.64 | 2.52 | -1.01 | -0.93 | -0.93 |
| EPS Diluted Total Ops | 0.71 | 2.40 | -1.01 | -0.93 | -0.93 |
| EPS Diluted Continuous Ops | 0.71 | 2.40 | -1.01 | -0.93 | -0.93 |
| EBITDA(a) | $12,415 | $140,446 | $-53,785 | $-47,611 | $-44,283 |